TY - JOUR
T1 - TIPS pentacene loaded PEO-PDLLA core-shell nanoparticles have similar cellular uptake dynamics in M1 and M2 macrophages and in corresponding in vivo microenvironments
AU - McDaniel, Dylan K.
AU - Jo, Ami
AU - Ringel-Scaia, Veronica M.
AU - Coutermarsh-Ott, Sheryl
AU - Rothschild, Daniel E.
AU - Powell, Michael D.
AU - Zhang, Rui
AU - Long, Timothy Edward
AU - Oestreich, Kenneth J.
AU - Riffle, Judy S.
AU - Davis, Richey M.
AU - Allen, Irving C.
PY - 2017/4/1
Y1 - 2017/4/1
N2 - Nanoparticle based drug delivery platforms have the potential to transform disease treatment paradigms and therapeutic strategies, especially in the context of pulmonary medicine. Once administered, nanoparticles disperse throughout the lung and many are phagocytosed by macrophages. However, there is a paucity of knowledge regarding cellular up-take dynamics of nanoparticles due largely to macrophage heterogeneity. To address this issue, we sought to better define nanoparticle up-take using polarized M1 and M2 macrophages and novel TIPS-pentacene loaded PEO-PDLLA nanoparticles. Our data reveal that primary macrophages polarized to either M1 or M2 phenotypes have similar levels of nanoparticle phagocytosis. Similarly, M1 and M2 polarized macrophages isolated from the lungs of mice following either acute (Th1) or allergic (Th2) airway inflammation also demonstrated equivalent levels of nanoparticle up-take. Together, these studies provide critical benchmark information pertaining to cellular up-take dynamics and biodistribution of nanoparticles in the context of clinically relevant inflammatory microenvironments.
AB - Nanoparticle based drug delivery platforms have the potential to transform disease treatment paradigms and therapeutic strategies, especially in the context of pulmonary medicine. Once administered, nanoparticles disperse throughout the lung and many are phagocytosed by macrophages. However, there is a paucity of knowledge regarding cellular up-take dynamics of nanoparticles due largely to macrophage heterogeneity. To address this issue, we sought to better define nanoparticle up-take using polarized M1 and M2 macrophages and novel TIPS-pentacene loaded PEO-PDLLA nanoparticles. Our data reveal that primary macrophages polarized to either M1 or M2 phenotypes have similar levels of nanoparticle phagocytosis. Similarly, M1 and M2 polarized macrophages isolated from the lungs of mice following either acute (Th1) or allergic (Th2) airway inflammation also demonstrated equivalent levels of nanoparticle up-take. Together, these studies provide critical benchmark information pertaining to cellular up-take dynamics and biodistribution of nanoparticles in the context of clinically relevant inflammatory microenvironments.
KW - Asthma
KW - Inflammation
KW - LPS
KW - Nanoparticle
KW - Pulmonary drug delivery
UR - http://www.scopus.com/inward/record.url?scp=85013857884&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85013857884&partnerID=8YFLogxK
U2 - 10.1016/j.nano.2016.12.015
DO - 10.1016/j.nano.2016.12.015
M3 - Article
C2 - 28040495
AN - SCOPUS:85013857884
SN - 1549-9634
VL - 13
SP - 1255
EP - 1266
JO - Nanomedicine: Nanotechnology, Biology, and Medicine
JF - Nanomedicine: Nanotechnology, Biology, and Medicine
IS - 3
ER -